Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 6.98
- Piotroski Score 4.00
- Grade Buy
- Symbol (HCC)
- Company Warrior Met Coal, Inc.
- Price $72.68
- Changes Percentage (3.87%)
- Change $2.71
- Day Low $70.71
- Day High $72.87
- Year High $75.53
Warrior Met Coal, Inc. produces and exports non-thermal metallurgical coal for the steel industry. It operates two underground mines located in Alabama. The company sells its metallurgical coal to a customer base of blast furnace steel producers located primarily in Europe, South America, and Asia. It also sells natural gas, which is extracted as a byproduct from coal production. Warrior Met Coal, Inc. was incorporated in 2015 and is headquartered in Brookwood, Alabama.
- Last Earnings 10/08/2024
- Ex-Dividend for 5/16 Dividend 11/05/2024
- Dividend Payable 11/12/2024
- Today N/A
- Next Earnings (Estimated) 02/12/2025
- Fiscal Year End N/A
- Average Stock Price Target $37.00
- High Stock Price Target $37.00
- Low Stock Price Target $37.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $8.31
- Trailing P/E Ratio 8.13
- Forward P/E Ratio 8.13
- P/E Growth 8.13
- Net Income $478.63 M
Income Statement
Quarterly
Annual
Latest News of HCC
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Warrior Met Coal, Inc. (HCC): A Bull Case Theory
Warrior Met Coal, a leading producer of metallurgical coal in the US, is highlighted for its strong financials and growth potential. The company's strategic focus and robust balance sheet position it ...
By Yahoo! Finance | 1 month ago -
FDA accepts BMS' sBLA for Opdivo-Yervoy combo for HCC
The FDA accepted BMS's sBLA for Opdivo and Yervoy as a potential first-line treatment for unresectable hepatocellular carcinoma. The submission is based on positive results from the Phase III CheckMat...
By Yahoo! Finance | 2 months ago -
Warrior Met Coal, Inc. (NYSE:HCC) Goes Ex-Dividend Soon
Warrior Met Coal, Inc. (NYSE:HCC) is trading ex-dividend in 3 days, paying US$0.08 per share. The company's dividend is covered by profits and cash flow, offering a sustainable payout with room for gr...
By Yahoo! Finance | 3 months ago
